
A new study has been launched to advance research into health conditions that affect South Asian communities at significantly higher rates, according to investigators.
The Genes & Health study aims to explore how genetics influence health, improve diagnosis and treatment, and ensure better representation of these communities in genomic research.
Residents of British Pakistani and Bangladeshi backgrounds in Wolverhampton and Walsall have been invited to participate.
“The research we conduct today will have a lasting impact on future generations, which is why we encourage as many people as possible from these communities to take part,” said Fahad Hossain of Walsall Manor Hospital.
Hossain, a consultant and director of research and development, added: “Understanding the role of genes in health and disease can lead to major advances in prediction, diagnosis, and treatment.
“Research has the potential to be life-changing, and we want to help people live healthier, longer lives.”
The study is being led by Queen Mary University of London in collaboration with healthcare trusts across the country, including The Royal Wolverhampton NHS Trust and Walsall Healthcare NHS Trust.
Researchers say the project aims to uncover why British Bangladeshi and Pakistani populations experience higher rates of conditions such as diabetes and cardiovascular disease, as well as generally poorer health outcomes.
Some participants may be invited to join further studies to provide deeper insights into specific health conditions.
Professor Tonny Veenith, clinical director of research at The Royal Wolverhampton NHS Trust, said: “We are proud that our Trusts are contributing to what is one of the world’s largest community-based genetic studies.
“Most major genetic research has focused on people of European backgrounds. This study is specifically designed for British Bangladeshi and British Pakistani communities, helping us better understand how to improve their health outcomes.”
Follow BBC Wolverhampton & Black Country on BBC Sounds, Facebook, X, and Instagram.
